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Essential collective dynamics analysisPyrabactin receptors (PYR) play a central role in abscisic acid (ABA) signal transduction; they are
ABA receptors that inhibit type 2C protein phosphatases (PP2C). Molecular aspects contributing to
increased basal activity of PYR against PP2C are studied by molecular dynamics (MD) simulations.
An extensive series of MD simulations of the apo-form of mutagenized PYR1 as a homodimer and
in complex with homology to ABA-insensitive 1 (HAB1) phosphatase are reported. In order to inves-
tigate the detailed molecular mechanisms mediating PYR1 activity, the MD data was analyzed by
essential collective dynamics (ECD), a novel approach that allows the identiﬁcation, with atomic res-
olution, of persistent dynamic correlations based on relatively short MD trajectories. Employing the
ECD method, the effects of select mutations on the structure and dynamics of the PYR1 complexes
were investigated and considered in the context of experimentally determined constitutive activi-
ties against HAB1. Approaches to rationally design constitutively active PYR1 constructs to increase
PP2C inhibition are discussed.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In 2009, two research groups independently reported the dis-
covery of a family of abscisic acid (ABA) -binding proteins in Ara-
bidopsis thaliana, containing as many as 14 members known as
PYR1 (pyrabactin resistance 1) and PYL (PYR1-like) [1] or RCAR
(regulatory component of ABA response) receptors [2]. In one
instance this was enabled by the identiﬁcation of pyrabactin as
an inhibitor of ABA-mediated developmental and stress response
effects in phenotypic screens [1]. Pyrabactin was shown to mediate
its inhibition through the pyrabactin receptor 1 protein (PYR1).
Further analyses showed that PYR1 and its associated homologs
play a central role in ABA signal transduction, as the ABA receptors,acting via inhibition of protein phosphatases of the type 2C (PP2C)
variety [1–3].
Structural studies have demonstrated that when ABA binds to
the receptor, interactions between the agonist and two ﬂexible
loops (Lb3b4 and Lb5b6 named gate and latch, respectively) form
a unique receptor surface (Fig. 1A) that can interact with the phos-
phatases [4,5]. Three independent studies also demonstrated that a
subset of the ABA receptors exhibit constitutive activity against
PP2Cs in vitro [1,6,7]. Although PYR1 and PYLs 1–3 show very weak
basal activity, PYL4 was found to be active against HAB1 [7],
whereas other family members such as PYLs 5–6 and 8–10 are con-
stitutively active. Based on analogy to the PYL10’s gate sequence,
recent work demonstrated that replacing residue V87 in PYL2’s
gate-latch region by the bulkier L87 equivalent fromPYL10 partially
increased PYL2’s constitutive inhibition of PP2C [7]. Further in this
vein, a less rational but more successfully applied broad based
mutagenic screening approach to the development of constitutive
active ABA receptors was recently reported [8]. In this instance
probing of 39 residues around ligand pocket in the ABA receptor
led to the identiﬁcation of 10 sites in the gate-latch and C-terminal
helix regions involved in mediating basal receptor activity.
Interestingly, although single-site mutations were sufﬁcient to
Fig. 1. PYR1 residues comprising the binding interfaces [10]: (A) – in PYR1–ABA–HAB1 complex, PDB ID 3QN1, with orange sticks showing PYR1 residues and green sticks
showing HAB1 residues; and (B) – in PYV/P2M-bound PYR1 dimer, PDB ID 3NJO, with orange and blue sticks showing the residues of chain A and B, respectively. The ligands
are depicted by translucent surfaces, colored according to the charge of ligand’s atoms: red – positive charge, blue – negative charge, white – no charge. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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analysis), stacking of 3 and even 4mutations was necessary to elicit
basal receptor activation at a level comparable to ABA-stimulated
receptor activity in vitro.
Recently it was demonstrated that ABA-receptors can adopt a
homodimeric form in solution (in the absence of ABA, see
Fig. 1B) and that this dimerization correlates with inhibition of
basal receptor activity. In particular, ABA-free PYR1, PYL1 and
PYL2 were found to be homodimeric, whereas PYLs 5–6 and 8–
10 adopt a preferentially monomeric form [9,7]. It has also been
shown [7] that mutation I88K in PYL2 both prevents homodimer
formation in solution and increases its constitutive activity. Resi-
due 60 in PYR1 has also been found to play a key role in determin-
ing the ABA-bound receptors’ oligomeric state [9].
Molecular dynamics (MD) simulations and associated essential
collective dynamics (ECD) analyses of wild type (WT) PYR1 in
homodimeric and PP2C complexes reported in our earlier study
[10], further support a ‘competing complexes’ model in which
PYR1–PYR1 dimerization might be in competition with formation
of PYR1–HAB1 complexes, in particular in the absence of ABA.
Addition of ABA yielded an opposite effect on the dynamics of
PYR1–HAB1 and PYR1–PYR1 complexes, constraining inter-molec-
ular interactions in the former and destabilizing the latter. An in
depth description of the ECD framework is available elsewhere
[10–14].
Now, MD simulations and associated ECD analyses of mutations
demonstrated, or predicted, to promote dissociation of the PYR1–
PYR1 dimer or promote the constitutively active association of
PYR1 with HAB1 are reported. Extensive MD simulations and
experiments for multiple mutants of PYR1 considered in the con-
text of complex formation with HAB1 versus homodimer were
undertaken. Employing the ECD framework we investigate the
effects of the mutations on structure and dynamics of the PYR1
complexes. We discuss promising PYR1 mutations and approaches
to design constitutively active PYR1 constructs.2. Results and discussion
2.1. Analysis of constitutively active PYR1 mutant constructs
A comparison of the interacting surfaces for PYR1 dimers versus
the PYR1–ABA–HAB1 complex [3,15,16], based on our MD simula-
tions analyses discussed elsewhere [10], shows that the interfaces
are largely the same in these two complexes. Examples of PYR1
binding areas in crystallographic structure of in ABA-bound com-
plex with HAB1 (PDB ID 3QN1) and PYV/P2M-bound dimer (PDB
ID 3NJO) shown in Fig. 1A and B, respectively, indicate that the
binding areas overlap signiﬁcantly. PYR1 residues involved in these
interactions, as identiﬁed by Accelrys VS, are listed in Table 1. The
table also presents the inter-molecular interaction data for apo-
PYR1 dimer for original X-ray crystallographic structure PDB ID
3K3K, as well as PYR1 residues contacting ABA for structure PDB
ID 3K3K. It can be seen that similar interactions are found in loops
La3b2, Lb3b4, the gate, and helix a5 in PYR1–ABA–HAB1 complex
and in both dimers. In apo-dimer, also the latch and the area of
helix Lb7a5 are involved in the interactions, similarly to the
PYR1–ABA–HAB1 complex. A detailed comparative analysis of
these interactions is presented elsewhere [10].
The overlap of the binding areas in PYR1 complexes with HAB1
and in the dimers complicates the task of identifying CA muta-
tions of PYR1 that might drive it to preferentially bind to PP2Cs
over forming homodimers in the absence of ABA. Thus activity
and structural information from published reports [8,18], as well
as available crystallographic structural data about ligand binding
sites in PYL10 [7], residues involved in intermolecular interac-
tions of PYL2 dimers [18] and interactions with phosphatase
[18] were also considered. Fig. S1 (Suppl. Mat.) presents a
sequence alignment for selected relevant PYR/PYL constructs,
highlighting 42 identiﬁed sites involved in ligand (L), HAB1 phos-
phatase (P), or intermolecular dimer (D) PYR1 contacts. A detailed
discussion of the considerations of these sites leading to the
Table 1
PYR1 residues involved in strong interactions in binding areas of PYR1–PYR1 and PYR1–ABA–HAB1 complexes, and residues interacting with ABA in PYR–ABA complex. The
donors or acceptors in hydrogen bonds have been identiﬁed within a 3.5 Å cutoff in ligand pocket. Other close neighbors of ABA have been identiﬁed within a 4 Å cutoff. The
activation mutations are from [6–9,18,15,16]. Round brackets indicate similar mutation sites for PYL2/PYL1.
PYR1
structure element
Interactions
PYR1/PYR1
dimer & PYV
Interactions
PYR1/PYR1
dimer apo
Interactions
PYR1/HAB1 ABA bound
PYR1 neighbors
of ABA
Constitutively
active (CA)
mutations
Activation
mutations &
ABA/PYV
Reference structure 3NJO.pdb [16] K3K.pdb [17] 3QN1.pdb [15] 3K3K.pdb [17] [8] [6–9,18,15,16]
La3b2 K63 H60, F61, K63 H60, F61, K63 K59, F61 H60, (F61) F61, (I62)
Lb3b4 I84 I84 I84 V83 V83, I84
Gate S85, L87 G86, P88 S85, G86, L87, P88 L87, P88, A89 L87, A89 S85, L87, P88, (A89)
b4, b5 S92, E94, F108, I110 E94, (I110)
Latch R116 R116, L117 H115, R116, F117, R116
b6, b7 Y120, S122, E141 Y120, E141
Lb7a5 N151 P148, N151 (N151) S152
a5 D155, M158 D155, M158, F159 D155, M158, F159 F159 M158, F159 R157H, (A160)
a5 L166 V163, L166 T162, L166 V163 T162, L166 (V163)
a5 Q169 Q169 N167, Q169 K170
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caption of Fig. S1.
Two types of CA inducing mutations can be envisioned based on
the ‘competing complexes’ model, including PYR1 dimer destabi-
lizing mutations versus mutations which enhance basal PYR1
interactions with PP2C. The ﬁrst type would require mainly non-
conservative mutations to drastically change the position of side
chains of neighboring residues at the core of the dimerization
interface [19]. To date, two types of dimer destabilizing mutations
have been characterized; both involving residues from the remain-
ing 19 potential CA mutation sites. These include mutation H60P in
the La3b2 region [9] and mutations in the C-terminal helix, such as
K170W, L166F, T162F, or M158I, and also F159V [8]. The M158I
and F159V pair is included in all CA mutant sets tested by Mosquna
et al. [8]. Structural considerations suggest these mutations poten-
tially lead to residue 158 being uniquely exposed at the binding
interface and residue 159 being buried behind neighboring residue
A160 in the ligand pocket, yielding a surface that could inhibit
dimer formation. Additional insight into potential dimer-dissociat-
ing mutations was gained upon consideration of the sequences of
other PYL receptors, such as PYL6 and PYL10, which show substan-
tially higher basal activity in comparison to PYR1 [7]. Sequential
sequence differences suggest that mutation K170W (polymor-
phism K170S) as well as D155E and D154E are likely primary fac-
tors deﬁning monomericity of PYR/PYL receptors when histidine is
retained at position 60, as in PYL6. The second type of mutations, to
enhance the PYR1–PP2C interaction, could be envisioned in two
distinct regions including, the gate-latch and the N-terminal part
of helix a5. For example gate-mutations such as V83F, L87F, or
A89W replace hydrophobic, non-polar residues with bigger and
even more hydrophobic side chains which tend to be involved in
stabilizing stacking interactions. Interestingly, it has been shown
that it is more efﬁcient to make only one or two mutations per ele-
ment of secondary structure of interest, potentially because exces-
sive additional volume cannot be accommodated [8]. Finally, as an
alternative, exploiting non-conservative substitutions in regions
distal from ligand or protein interaction surfaces, by analogy with
strongly CA PYL6 and PYL10, was also investigated. Toward this,
the set of potential activation sites was extended to include those
with minor allele frequencies including R50, D53, T93, and V138
(Suppl. Mat. Fig. S2).
All together, ten conservative and non-conservative amino acid
substitutions, R50S, D53E, H60P, V83I, V83F, L87I, T93L, V138R,
F158I, and V159V, were constructed by in silicomutagenesis which
may be expected to favor the closed lid conformation in ABA-free
PYR1, or imitate strong inter- and intra-protein correlations
observed in the PYR1–ABA–HAB1 complex, or else destabilize theABA-free dimer. Four mutation sets were analyzed numerically in
this paper. In particular, Models 1 and 2 represent previously
reported mutated PYR1 constructs H60P [9] and H60P V83F
M158I F159V [8], respectively. Models 3 and 4 comprise sets of
mutations R50S D53E T93L V138R and D53E H60P V83I L87I
F159V, which have not been explored before. Furthermore, Models
2, 3, and 4 were also assessed experimentally. Below we report
results of these experiments as well as a comparative MD simula-
tion ECD analysis of these sets of mutations.
2.2. Constitutive activity of PYR1 mutants
The constitutive activity of PYR1 and its mutants were analyzed
using the phosphatase activity assay. 1:2.5 and 1:25 M ratios of
phosphatase: receptors were tested in these assays. CA receptors
are expected to show a reduction of phosphatase activity even in
the absence of (+) ABA. PYR1 showed no constitutive activity at
both ratios, while Model 2 showed high constitutive activity even
at the lower molar ratio and inhibited phosphatase activity to the
same level as ABA (Fig. 2). Model 3 did not show any constitutive
activity at both the molar ratios tested. Finally Model 4 was not
active at the lower molar ratio of 1:2.5, however, at higher molar
ratio of 1:25, it showed nearly 60% inhibition of phosphatase activ-
ity (Fig. 2). All four proteins showed similar responses to ABA
showing that they were all functionally active as ABA receptors.
Overall this set of mutant PYR1 models present an array of CA
activities for comparative investigation by MD simulations and
ECD analyses.
2.3. Comparative ECD analysis of mutant and wild type PYR1
complexes
For each of the four mutated models, ECD analysis of 100 seg-
ments of the corresponding MD trajectories was performed and
results averaged as described in Section 3. Comparisons of the
ECD descriptors for the mutants in the form of ABA-free PYR1
dimers and PYR1–HAB1-complexes with respect to WT PYR1
equivalents from [10] were made to interpret the experimental
observations as well as further clarify the mechanisms associated
with mutations that would mimic the dynamics of the PYR1–
ABA–HAB1 complex in the absence of ABA while destabilizing
the ABA-free dimer construct as much as possible.
2.3.1. Model 1
Model 1 contains a single dimer destabilizing mutation H60P,
which has been characterized previously in vitro and is expected
to weaken afﬁnity in the dimer [9]. Thus the numerical analysis
Fig. 2. In vitro phosphatase assay of HAB1 alone (green bars), HAB1 + PYR (1:2.5
ratio) (orange), HAB1 + PYR (1:25 ratio) (brown) and HAB1 + PYR (1:2.5 ratio) +
1 lM (+) ABA (red bars). The ﬂuorescence of HAB1 alone was set as 100%. Each bar
shows the average % activity of three replicates and ±standard deviation. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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following discussion of other mutated constructs. The PYR1 ABA-
free dimer and PYR1–HAB1 binding interfaces for Model 1 are
shown in Fig. 3, panels (A) and (B), respectively. In PYR1 dimer,
mutation H60P affects the orientation of neighboring residue
F61, preventing binding to Lb3b4 and the N-terminus of helix a5
(P88(B)–M158(A)) asymmetrically. However, a close contact per-
sists at the interface of mutant dimer (Fig. 3A). As concerns the
PYR1–HAB1 binding interface, mutation H60P prevents F61 from
binding to residues E323 and Y404 of the phosphatase (Fig. 3B).
Fig. 4 compares the ECD main chain ﬂexibilities proﬁles for a
WT PYR1 dimer containing two ABA molecules, denoted here as
2ABA-bound PYR1 dimer, with WT ABA-free apo dimer and ABA-
free Model 1 mutant dimer. In the ﬂexibility proﬁles, peaks of
the descriptor FCai are usually observed in the areas of ﬂexible loops
of the protein, whereas minima or low-leveled plateaus, as a rule,
correspond to more rigid b-sheets or a-helices. As it can be seenFig. 3. Close up of the binding area for ABA-free dimer (A) and ABA-free PYR1–HAB1 com
on binding surfaces are indicated according to [8]. The PYR1’s F61 are depicted with yello
In (A), the mutation H60P in dimer affects the orientation of the main chain A around re
complex in (B) can also prevent bonds formation between residues F61, L166 (not shown
references to color in this ﬁgure legend, the reader is referred to the web version of thifrom Fig. 4, loops La1b1, Lb2b3 and Lb6b7, as well as C-terminus
of helix a5 exhibit a high ﬂexibility for all three PYR1 systems in
Fig. 4; the latch is pronouncedly ﬂexible in 2-ABA bound dimer,
but to a lesser extent in the apo-dimers; whereas the ﬂexibility
maximum in the area of loop Lb7a5 is somewhat shifted toward
the N-terminus, particularly in the case of two WT systems.
Fig. 4 also shows that the main chain ﬂexibility of ABA-free H60P
mutant dimer (Model 1) is very close to that of 2ABA-bound and
ABA-freeWT dimers, except for regions near the gate and the latch,
Lb7a5, C-terminal part of a-helix a5, and residues 20–35. Interest-
ingly, the ﬂexibilities of chains A in both mutated Model 1 and WT
ABA-free dimers exhibit a pronounced plateau in the regions of the
latch and C-terminus of helix a5. In WT 2ABA-bound dimer, high
ﬂexibility in the latch region is related to the interaction of P88
with ABA, resulting in a decoupling of loop Lb5a4 and helix a4
(the latch) from the rest of PYR1. Since mutation H60P results in
a similar ﬂexibility proﬁle, the mutation evidently affects not only
the neighboring F61, but also inﬂuences relatively distant residue
P88. The ﬂexibility of chain A Model 1 mutant dimer is higher in
the region of residues 148–151, which is attributable to disruption
of bonds at residues N151 and P148. All proﬁles in Fig. 4 show a
low ﬂexibility of critical regions around residue 60 and N-terminus
of helix a5, while in the area of the gate the ﬂexibility of Model 1
dimer is slightly lower than that of both WT dimers. In the area of
the latch, ﬂexibility of chain A in Model 1 dimer is slightly lower
than that in WT apo-dimer and pronouncedly lower than in
2ABA-bound dimer. The main chain ﬂexibilities of chains B in the
three dimer systems are shown on Fig. S3 (Suppl. Mat.). From com-
parison of the plots in Fig. 4 and Fig. S3 it is evident that the pres-
ence of the ligand or mutation affects dynamics of the chains
asymmetrically. In distinction to chain A, the ﬂexibility proﬁles
of chain B in all three dimer systems are almost identical, with
an exception of slightly higher ﬂexibility of loop Lb7a5 in 2ABA-
bound WT dimer and slightly higher ﬂexibility of loop Lb6b7 in
Model 1 mutant.
Complementary to the ECD ﬂexibility proﬁles, we have also ana-
lyzed Ca atoms correlationmaps (see Section 3 for technical details).plex (B) fromMD simulations using Accelrys VS for Model 1. The important residues
w sticks, P88 with blue sticks and the residues M158 are depicted with green sticks.
sidue F61, which repels chain B residue F61. The same mutation in the PYR1–HAB1
), and Y404 (not shown), E323 (depicted with gray sticks). (For interpretation of the
s article.)
Fig. 4. PYR1 main chain ﬂexibility proﬁles for chain A of dimer constructs: WT ABA-free (green line), WT 2ABA-bound (red line), and ABA-free H60P mutant (denoted as
Model 1, blue line). Vertical dashed lines indicate the potential mutation sites and regions of phosphatase binding. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
Fig. 5. Ca atoms correlation maps for intra-receptor (A) and inter-molecular (B) correlations in WT PYR1–ABA–HAB1 complex. Strong correlations are shown in green and
dark blue colors (low levels of the correlation descriptor), while weaker correlations are shown with white and light magenta colors (high levels of the descriptor, see also
Section 3). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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for thePYR1–ABA–HAB1complexare shown in Fig. 5AandB, respec-
tively. The maps represent correlations betweenmain chain carbon
atoms, including direct contacts, steric constraints and water- or
ions-mediated secondary interactions. One can see strong intra-
molecular correlations for all structural elements of PYR1 in region
of residues 26–180, whereas the areas of loops La3b2, b3b4, the
latch, sheet b7, and helix a5 show strong inter-molecular correla-
tionswithHAB1 residues. In order to facilitate the comparative anal-
ysis of PYR1 mutants dynamics, difference correlation maps were
also analyzed for the various complexes relative to a control con-
struct, as described in Section 3. Fig. 6A–D present examples of dif-
ference correlation maps for intra-molecular correlations (A,C) and
inter-molecular correlations (B,D) in WT PYR1 dimer (A,B) and
PYR1–HAB1 complex (C,D) (for dimers ABA-free (apo) WT PYR1–
PYR1 constructs were used as a control, whereas for PYR1–HAB1
complexes ABA-bound WT PYR1–ABA–HAB1 constructs were used
as a control). In the dimer system, according to Fig. 6A, binding of
two ABA molecules weakens intra-molecular correlations of the
latch with the rest of receptor, but strengthens the correlations in
the area of helix a1. The corresponding changes of inter-molecular
correlations (Fig. 6B), in turn, are asymmetrical and show a partialloss of correlations at the latch in chain A and around the loops
Lb3b4 and Lb7a5 aswell as the latch in chain B. In PYR1–HAB1 com-
plex, absence of ABA decreases PYR1 intra-molecular correlations in
helix a5 and at the latch, but strengthens correlations of helix a1
with the rest of the molecule (Fig. 6C). Finally, inter-molecular cor-
relations of PYR1 in ABA-free PYR1–HAB1 complex are weakened
at various locations, in particular with HAB1’s regions around 460,
310, 280 and 230. Interestingly, all these residues are located on
loops distant from the binding surface. One can infer that absence
of ABA indirectly affects the dynamics of distant regions of HAB1.
Fig. S4A and S4B present difference intra-molecular and inter-
molecular correlation maps for the mutant Model 1 dimer against
WT ABA-free dimer complex (control). It can be seen that Model 1
exhibits a partial loss of intra-receptor correlations in the regions
of the loop Lb7a5 and helix a5 of the dimer (red colored areas in
Fig. S4A). This loss of correlation is consistent with the Lb7a5
decoupling observed in the dimer ﬂexibility proﬁle for Model 1
(Fig. 4). At the same time, stronger inter-molecular correlation
between N-terminal helix a1, loops La1b1 and Lb3b4 and also
the latch of chain A with b-sheets and helices a1 and a5 of chain
B is observed in Model 1 in comparison with the WT apo-dimer
(see green colored areas in Fig. S4B).
Fig. 6. Difference intra-molecular (A, C) and inter-molecular (B, D) Ca atoms correlation maps relative to control for 2ABA-bound PYR1 dimer (A, B) and ABA-free PYR1–HAB1
complex (C, D); intra-molecular correlation maps were built for chain A residues of dimer (A), while inter-molecular correlation maps present chain A residues on horizontal
axis and chain B on vertical axis (B). For control, ABA-free PYR1 dimer was used in (A, B) and PYR1–ABA–HAB1 complex in (C, D). In the difference maps, green color indicates
stronger correlation than in the control, and red color indicates less constrained and more ﬂexible regions than in the control. White color indicates regions with the same
level of correlations. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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dynamics of the PYR1–ABA–HAB1 complex in the absence of
ABA, we have also compared the ﬂexibility proﬁles and correlation
maps of ABA-free, Model 1 mutant PYR1–HAB1 construct with the
WT ABA-bound construct. Fig. S5 compares the corresponding ﬂex-
ibility proﬁles for both PYR1 and HAB1 main chains; Fig. S6A pre-
sents the difference intra-molecular correlation map for PYR1 in
PYR1–HAB1 complex; and Fig. S6B shows the difference inter-
molecular correlation map for this complex. As one can see from
Fig. S5, in ABA-free H60P mutant the main-chain ﬂexibility of
HAB1 is considerably increased around residues G226, N227,
S228, and N458. The corresponding loops are situated at the oppo-
site side from the binding area of the phosphatase with PYR1, indi-
cating that even a single mutation in ABA-free receptor may affect
the dynamics of very distant regions of the phosphatase. From
Fig. S5 it is evident that mutant Model 1 PYR1 residues shows
encouraging agreement with the ﬂexibility proﬁle of WT PYR1–
ABA–HAB1 construct. However, the correlation maps in Fig. S6
(A, B) reveal differences. For example, mutant Model 1 shows
slightly weaker intra-PYR1 correlations in the loops Lb7a5 and
Lb6b7 than observed in WT ABA-bound complex (Fig. S6A).
Stronger inter-molecular correlations is observed between PYR1’s
alpha-helix a1 and sheet b2 with most HAB1 residues, whereas
correlation with HAB’s residues G226 and N458 (situated distantlyfrom the binding surface area) is weakened strongly for all residues
of PYR1 (Fig. S6B). Mutation Model 1 reproduces reasonably well
the coupling of the latch, sheet b7, and helix a5 with HAB1 resi-
dues 230–420 as found in PYR1–ABA–HAB1 complex, however it
fails to reproduce some of the strong correlations for the loops
La3b2, Lb3b4 and Lb6b7 with the phosphatase (Fig. S6B).
One can conclude that Model 1 weakens inter-molecular corre-
lations around sheets b1, b5, and b7, and helices a3 and a5 in the
dimer, however it tends to loosen PYR1 bonding with HAB’s N-ter
and C-ter residues in the mutant apo-PYR1–HAB1 complex in com-
parison to WT PYR1–ABA–HAB1 complex (see Fig. S4B and S6B). In
dimer, mutation H60P has been shown to affect the orientation of
residue F61 in chain A, which repels chain B’s residue F61 [9], how-
ever our analysis indicates that this does not decrease signiﬁcantly
the inter- and intra-molecular correlations in the area of loop
La3b2. In the PYR1–HAB1 complex, mutation H60P slightly weak-
ens the correlation between PYR1 region around residue F61 (loop
La3b2) and all HAB1 residues except N277 and H224.
2.3.2. Models 2 and 4
Out of all mutated constructs, the closest dynamical matches to
the WT PYR1–ABA–HAB1 system was achieved with Model 2
(H60P, V83F, M158I, F159V) [8] and Model 4 (D53E, H60P, V83I,
L87I, F159V). Fig. 7 (A, B) and (C, D) present PYR1–PYR1 and
Fig. 7. Close up of the binding area for ABA-free dimer (A, C) and ABA-free PYR1–HAB1 complex (B, D) after 20 ns simulations for Model 2 (A, B) and Model 4 (C, D). The color
scheme used is the same as for Fig. 3. In dimer, the orientation of side chain at F61 is similar as in Model 1, and in Model 2 it is slightly rotated. In PYR1–HAB1 complex,
residue F61 leans towards PYR1 in both mutant models, and the bonding with E323, T324 and Y404 is not affected. In Model 4 strong bonding with T324 is observed. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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As it can be seen in Fig. 7A and C, the binding interface for PYR1
mutant dimers of Models 2 and 4 is the same as in Model 1, with
the exception of a slight rotation of F61 residues for Model 2 and
changes in orientation of residue 158 for Model 4. In the PYR1–
HAB1 binding interface (Fig. 7B and D for Models 2 and 4, respec-
tively), the presence of other mutations than H60P does not change
the orientation of residue F61, which remains rotated towards
PYR1 receptor, allowing binding contacts with residues E323,
T324, and Y404 of the phosphatase.
In Fig. 8 the ﬂexibility of chains A in mutant dimers is compared
with that of WT ABA-free WT dimer. According to the ﬁgure, there
are quite signiﬁcant differences among the proﬁles in Fig. 8. For
both Models 2 and 4, the main chain ﬂexibility in the areas of helix
a5 and sheet b1 is lower, and that of loop Lb7a5 is higher than in
the WT construct. Also in Model 4 mutant dimer a lower ﬂexibility
of the latch in comparison with the WT construct has been found,which might be related to mutation V83F. Interestingly, in contrast
to all mutant dimer Models 1–4, both 2ABA-bound and ABA-free
WT dimers exhibit a minimum around PYR1 residue S152 and a
maximum around PYR1 T156 in the ﬂexibility proﬁles (see Figs. 4
and 8). In the mutant constructs, both the minimum of PYR1 ﬂex-
ibility at S152 and maximum at T156 are absent. As it can be seen
elsewhere (Fig. 8 of Ref. [10]), these features are also absent for the
WT PYR1–ABA–HAB1 complex. This suggests that the sets of muta-
tions introduced may disrupt interactions of chain A loop Lb7a5
with chain B in the dimers; however this loop is also less con-
strained in ABA-bound PYR1–HAB1 complex. Similarly to Model
1, the ﬂexibility of chains B in mutant dimers of Model 2 and 4
(not shown) is very close to that of WT ABA-free dimer.
Fig. 9 presents difference maps for intra-molecular and inter-
molecular correlations in Model 2 and Model 4 PYR1 dimers rela-
tive to the WT ABA-free dimer (control). When combined with
other PYR1 mutations in Models 2 and 4, mutation H60P does
Fig. 8. PYR1 main chain ﬂexibility proﬁles for chain A dimer constructs: WT ABA-free (green line), ABA-free Model 2 mutant (yellow line), ABA-free Model 3 mutant (blue
line), and ABA-free Model 4 mutant (red line). Vertical dashed lines indicate the potential mutation sites and regions of phosphatase binding. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 9. Difference Ca atoms correlation maps for PYR1 dimer Model 2 (mutations H60P V83F M158I F159 V; panels A, C) and Model 4 (mutations D53E, H60P, V83I, L87I,
F159 V; panels B, D) against the control WT PYR1 dimer construct: intra-receptor chain A Ca atoms difference correlation maps (A, B) and inter-molecular Ca atoms difference
correlation maps (C, D). The color scheme is as in Fig. 6. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
L. Dorosh et al. / FEBS Open Bio 4 (2014) 496–509 503not weaken intra-receptor correlations in the a5 region, which
remains constrained by the other mutations (see Fig. 9A and B,
respectively). However, intra-receptor correlations are weakened
in the regions of Lb6b7 loop, helix a1, and sheet b2 when mutation
H60P is combined with D53E, V83I, L87I, and F159V (Model 4, seeFig. 9B), and around loops Lb2b3, the gate, and Lb6b7 when it is
combined with mutations V83F, M158I, and F159V (Model 2, see
Fig. 9A). The difference maps for inter-molecular correlations in
dimer mutants (Fig. 9C and D) show an asymmetry in the dimer
interactions. Distinctive for Model 2 mutant dimer, weak correla-
504 L. Dorosh et al. / FEBS Open Bio 4 (2014) 496–509tions of helix a1 of chain B and chain A loop Lb7a5 with most of
residues in chains A and B, respectively have been observed
(Fig. 9C). In turn for Model 4 mutant dimer, weakened correlations
of chain A sheet b2 and chain B loop Lb7a5 with most of the coun-
terpart chains B and A, respectively, were found. However, inter-
molecular correlations of chain A region 25–50 with most of chain
B are more pronounced in Model 4 than in Model 2 (Fig. 9D). Com-
bining mutation H60P with other mutations in Models 2 and 4
does not seem to signiﬁcantly reduce correlations in helix a3 and
most other regions in comparison with Model 1 (see Fig. S4B,
Fig. 9C and D).
Comparison of PYR1 main chain ﬂexibility proﬁles for Models 2
and 4 mutant PYR1–HAB1 complexes with WT PYR1–ABA–HAB1
complex (Fig. 10A) shows a very good agreement. In the case of
Model 2, a slightly higher level of ﬂexibility is observed for the gate
and loop La3b2 region, while for Model 4, a slightly higher ﬂexibil-
ity is found for the loop Lb7a5. These differences are of similar
magnitude as the difference in the receptor’s main chain ﬂexibility
in PYR1–ABA–HAB1 and PYR1–HAB1 complexes as demonstrated
elsewhere ([10], Fig. 8).
Fig. 11 (A–D) present PYR1–HAB1 intra-receptor (A, B) and
inter-molecular (C, D) difference correlation maps for Model 2 (A,
C) and Model 4 (B, D). For both Models 2 and 4, all correlations
between helix a1 with most HAB1 regions, as well as inter-molec-
ular correlations between HAB1’s residue 223 with all PYR1
regions, are stronger than in the control construct WT PYR1–
ABA–HAB1. In comparison with Model 2, Model 4 exhibits stronger
intra-molecular (Fig. 11A and B) and inter-molecular (Fig. 11 C and
D) correlations in the regions of PYR1 gate loop, whereas theFig. 10. PYR1 main chain ﬂexibility proﬁles for PYR1–HAB1 constructs: (A) – ABA-bound
ABA-free mutant D53E H60P V83I L87I F159 V (Model 4) (blue line); (B) – ABA-bound
Vertical lines indicate the potential mutation sites and regions of phosphatase binding. (F
to the web version of this article.)correlations are weaker in the area of loop Lb7a5, and also in the
N-terminus region 1–6. Fig. 11C and D further demonstrate that
Model 4 shows a higher level of inter-molecular correlations, in
comparison with Model 2, between the areas of PYR1 gate, loop
La3b2, and helix a5 with several broad HAB1 regions, especially
with residues 306–320. The correlations with HAB residues 185–
210, 235–260, 280–305, 340–350, 360–370, 380–415, 430–440,
and 475–500 are also higher in Model 4 than in Model 2. In con-
trast, correlations of most PYR1 residues with HAB region 457–
470 are stronger in Model 2 than in Model 4.
Overall, one can conclude that both Models 2 and 4 have the
potential to improve the binding of PYR1 with PP2C in the absence
of ABA ligand. Model 4 mutant exhibits more pronounced inter-
molecular correlations with HAB’s regions around residues 306–
320, whereas Model 2 improves the correlations with the area
around HAB residues 457–470. This is consistent with previous
in vitro data [8] and the in vitro comparison presented herein dem-
onstrating strong CA for Model 2 and weaker CA (evident only at
higher ratios of receptor to phosphatase) for Model 4 (Fig. 2). The
need for stronger constraints in the C-terminal helix a5 and loop
Lb7a5 may account for Model 4’s lower relative CA, which could
be achieved by replacing mutation H60P with L166F K170W posi-
tioned in the same region.
2.3.3. Model 3
Model 3 mutations comprise R50S, D53E, T93L, and V138R.
Comparison of the main chain ﬂexibility proﬁle for ABA-free Model
3 dimer with that of the WT ABA-free dimer in Fig. 8 shows that
the ﬂexibility of the mutant dimer is somewhat different from thatWT (green line), ABA-free mutant H60P V83F M158I F159 V (Model 2) (red line) and
WT (green line), ABA-free mutant R50S D53E T93L V138R (Model 3) (yellow line).
or interpretation of the references to color in this ﬁgure legend, the reader is referred
Fig. 11. Difference intra-molecular (A,B) and inter-molecular (C,D) Ca atoms correlation maps for Model 2 (mutations H60P V83F M158I F159 V; panels A and C) and Model 4
(mutations D53E, H60P, V83I, L87I, F159 V; panels B and D) PYR1–HAB1 complex against the control WT PYR1–ABA–HAB1 construct. The color scheme is as in Fig. 6. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Lb2b3, Lb7a5, and helices a2 and a5. Interestingly, the ﬂexibilities
of chains A in both mutated Model 3 and WT ABA-free dimer exhi-
bit a slightly higher ﬂexibility of the latch in comparison to Model
2 and Model 4 mutants. At the same time, the ﬂexibility of loops
Lb2b3 and Lb7a5 are pronouncedly higher for Model 3 mutant
than for WT dimer or other mutant models.
The difference intra-molecular and inter-molecular correlation
maps for mutant Model 3 dimers against WT ABA-free dimer (con-
trol) are shown on Fig. 12A and B, respectively. Similarly to Models
2 and 4 (see Fig. 9A and B), intra-receptor correlations are
improved for loop La1b1, and weakened for loop Lb7a5 and sheet
b2, in comparison to the control construct. Inter-molecular correla-
tions for Model 3 against control show a strong increase in corre-
lation for N-terminal part 7–60, helix a5 and a decrease in
correlation around sheet b2 and loop Lb7a5.
In Fig. 10B, main-chain ﬂexibility of Model 3 receptor from
PYR1–HAB1 complex is compared with that of the benchmark
WT PYR1–ABA–HAB1 construct. Interestingly, although none of
the mutation sites in Model 3 (R50S, D53E, T93L, and V138R) are
close to the PYR1 ligand pocket or directly involved in the binding
to HAB1, this mutation set reproduces very well the most impor-
tant main chain ﬂexibility features of the benchmark system WT
PYR1–ABA–HAB1, except for a slightly higher ﬂexibility in the gatearea and helix a1. The difference in the ﬂexibility proﬁles is com-
parable to that for WT PYR1–HAB1 and WT PYR1–ABA–HAB1 con-
structs described elsewhere [10]. The intra-receptor difference
correlation map of Model 3 PYR1–HAB1 complex against WT
PYR1–ABA–HAB control construct (Fig. 12C) is similar to that of
Model 2 (Fig. 11A). Slightly stronger correlations in comparison
to Model 2 are discernible in the regions of loops La1b1, Lb1a2,
and Lb6b7, albeit pronouncedly weaker correlations are observed
around helix a1. Difference inter-molecular correlation map for
Model 3 PYR1–HAB1 complex against WT PYR1–ABA–HAB1 con-
trol (Fig. 12D) shows a weakening of correlations of PYR1 regions
1–15, 45–70, 75–95, and 150–175 with HAB1, and an increase in
the correlations of loop La1b1 with most of HAB1 main chain.
One can hypothesize that a certain change in the topology of the
binding area is induced by mutating residues R50 and V138. These
mutations may produce conformational changes which would con-
strain the loop Lb7a5 of ABA-free PYR1, and also allow the receptor
to adopt a conformation close to the ABA-bound one, thereby sta-
bilizing the mutant PYR1–HAB1 complex (Fig. 12B). However no
evidence of constitutive activity is observed for this model
in vitro (Fig. 2), emphasizing overall that neither bulk destabiliza-
tion of the dimer interface or stabilization of the HAB1 interface
by altering main-chain ﬂexibility features are in themselves sufﬁ-
cient to elicit CA. The importance of directly stabilizing the
Fig. 12. Difference intra-molecular (A, C) and inter-molecular (B, D) chain A Ca atoms correlation maps for Model 3 (mutations R50S, D53E, T93L, V138R) dimer against the
control WT dimer construct (A, B), and Ca atoms correlation maps for Model 3 PYR1–HAB1 complex against the control WT PYR1–ABA–HAB1 construct (C, D). The color
schemes are as in Fig. 6. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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further improved by introducing the gate-stabilizing mutation
V83I and dimer destabilizing mutation K170W.
In summary, an extensive series of MD simulations of the apo-
form of mutagenized pyrabactin receptor PYR1 as a homodimer
and in complex with HAB1 phosphatase are reported, and molecu-
lar motions (dynamics) aspects contributing to increased basal
activity of pyrabactin receptors PYR1 against HAB1 investigated
by the novel ECD method. Several sets of PYR1 mutations expected
to favor the closed lid conformation in ABA-free PYR1, imitate
strong inter- and intra-protein correlations of atomic motion
observed in the benchmark WT PYR1–ABA–HAB1 complex, while
destabilizing the ABA-free dimer, are assessed. The most signiﬁcant
differences in the ﬂexibility proﬁles and correlation maps among
the mutants as well as in comparison to their WT counterparts is
found in the dimeric complexes. Although intra-receptor correla-
tions are generally weaker in mutant PYR1–PYR1 dimers than in
mutant PYR1–HAB1 complexes, the differences in correlations aris-
ing from the introduction of mutations are more pronounced for
the dimer systems. Dynamics of HAB1-bound PYR1 were less
responsive to the mutations. ABA-free mutant PYR1–HAB1 com-
plexes and WT PYR1–ABA–HAB1 systems show almost identical
main chain ﬂexibility and mostly slight differences in intra-molec-
ular and inter-molecular correlations. In general, the most signiﬁ-
cant changes of the dynamics in response to the mutations areobserved around the loops La1b1, Lb7a5, latch (Lb5b6), and in
sheet b2 of PYR1. Single dimer destabilizing mutation H60P (Model
1, [9]) was found to constrain the helix a1, sheet b2, and the loop
La1b1 in the PYR1–HAB1 complex while destabilizing the loop
Lb7a5 and helix a5 in the dimer. When mutation H60P is
combined with other three mutations V83F, M158I, F159V, the
resulting Model 2 [8] acquires stronger intra-molecular and
inter-molecular correlations in the areas of sheets b2 and b7, as
well as at the loop La1b1 in both complexes, reproducing fairly
well the intra-molecular correlation map of WT receptor in
PYR1–ABA–HAB1 complex. While all mutation models considered
reproduce very well the main chain ﬂexibility proﬁle of the bench-
mark WT PYR1–ABA–HAB1 construct, the most promising results
were achieved both theoretically and experimentally with the sets
of mutations H60P, V83F, M158I, F159V (Model 2, [8]) and D53E,
H60P, V83I, L87I, F159V (Model 4). Simulations for Model 4 show
that these mutations strengthen the binding between HAB1 and
PYR1, especially in the regions of the gate and loop La3b2. The
model also stabilizes helix a5 and improves the binding of it to
the phosphatase. However, our simulations also suggest that this
model may stabilize the interaction of PYR1 in the dimer, particu-
larly involving residues 25–50. One can hypothesize that Model 4
could be further improved by replacing mutation H60P with
L166F K170W. The latter is a promising double mutation not yet
tested experimentally which may be expected to stabilize the
L. Dorosh et al. / FEBS Open Bio 4 (2014) 496–509 507binding with phosphatase while decreasing the likelihood of PYR1
dimerization. The Model 3 mutation set R50S, D53E, T93L, and
V138R is different from other models considered since none of
the four mutations is in proximity to the ligand pocket or PP2C/
dimer binding interface. Nevertheless, this set shows promising
ﬂexibility and binding performance, improving the correlation of
loop La1b1 with HAB1, although not yielding any CA experimen-
tally. One can hypothesize that the mutations distant from the
binding surface, such as D53E or R50S, may affect stability of the
receptor and orientation of residues on the binding interface. How-
ever in comparison to Model 2, Model 3 lacks correlations with
HAB’s region around residue 460, and it also appears to stabilize
the region 25–50 of the dimer. We expect that Model 3 may be fur-
ther improved by introducing gate-stabilizing mutation V83I and
dimer destabilizing mutation K170W.
In contrast to earlier work reporting that triple and quadruple
mutant combinations in the regions of the loop La3b2, the gate,
and helix a5 (as implemented in Model 2) are sufﬁcient for full
receptor activation, the simulations reported herein suggest a
more complex relationship. While simulations do suggest that
the mutations induce promising changes of dynamics in the
described regions, the simulations also suggest a possibility of an
increased afﬁnity of PYR1 for itself. Our data support the hypothe-
sis that formation of dimers is in competition with the PP2C inter-
actions for the mutated receptor constructs, and suggest that
certain sets of mutations may favor one complex over the other.
Our results also indicate that even a single mutation of PYR1 recep-
tor may affect the dynamics of the entire PYR1–HAB1 complex, in
particular the ﬂexibility and inter-molecular correlations of distant
from the binding surface regions of the phosphatase.
Overall, we anticipate that the described effects of mutations
could be applicable for other dimeric pyrabactin-like-receptors, if
considered in the context of individual sequence peculiarities.
The mutations employed in Models 2 and 4 to enhance the binding
to PP2C in particular might also improve activity in monomeric
PYLs.
3. Materials and methods
3.1. In vitro mutant receptor activity assays
Details of protein preparation and assay are essentially as
described previously [2]. The cDNA encoding A. thaliana PYR1
was cloned into the pET 100 vector (Invitrogen) to include an N-
terminal His-Tag. This construct was introduced into Escherichia
coli BL21 star (DE3), where recombinant expression of the PYR1
cDNA was induced by additional of 0.25 mM or 1.0 mM IPTG.
HAB1 was cloned into pDEST17 (Invitrogen) also with an N-termi-
nal HIS0tag, and introduced into E. coli BL21 AI cells, where its
expression was induced by the addition of 0.2% arabinose. DNA
encoding PYR1 with H60P, V83F, M158I, F159V (Set #3Model #2)
mutations, PYR1 with R50S, D53E, T93L, V138R mutations (Set
#4Model #3) and PYR1 with D53E, H60P, V83I, L87I, F159V muta-
tions (Set #5Model #4) was synthesized and cloned into the pEX-
N-His vector by Blue Heron Biotech, LLC (Bothell, WA, USA), whichTable 2
List of 3D PYR1 constructs taken from PDB and modeled in silico, which were used for MD
Construct PYR1 dimer
Ligand free PYV/P2M extracted from 3NJO [16], S88 replaced with P88
Ligand-
bound
(1) PYV/P2M replaced with two ABA and S88 replaced with P88 in 3NJ
(2) PYV replaced with one ABA, P2M removed, and S88P mutation in 3
Apo-
mutants
Mutant models based on chains A and B of 3NJO with PYV/P2M extracte
mutation [16]were introduced into E. coli BL21 star (DE3) where gene expression
was induced by addition of 0.25 mM or 1.0 mM IPTG. All induced
cultures were incubated overnight at 16 C. The cell pellets were
frozen in liquid nitrogen and stored at 80 C. Frozen cell pellets
were thawed and the ﬁnal volume was made up to 20 mL using
the lysis buffer (100 mM Tris pH 7.9, 100 mM NaCl, 0.3 mM MnCl2
and 4 mM DTT) containing 10 mM imidazole. The cells were lysed
using the French press at 1000 psi. The cell lysate was clariﬁed by
centrifuging at 17,000 rpm for 25 min at 4 C. The supernatant was
quickly removed and used for further puriﬁcation. Puriﬁcation was
carried out by taking 4 mL of Ni–NTA (50% suspension) (QIAGEN)
in a plastic column and washed thrice with 5 mL of lysis buffer
containing 10 mM imidazole. The washed Ni–NTA resin was added
to the cell lysate supernatant and incubated at 4 C for 30 min. Elu-
tion of the bound protein was performed by adding 4 mL fractions
of lysis buffer containing 150 mM imidazole till all proteins were
eluted from the column. The ratio of HAB1:PYR1 was set at 1:2.5
and 1:25 with the HAB1 concentration set at 0.5 lM. PYR1 or
mutant PYR1 was added to the phosphatase at 1.25 and 12.5 lM
ﬁnal concentrations respectively, in a 100 ll reaction mixture, in
a buffer containing 100 mM Tris pH 7.9, 100 mM NaCl, 0.3 mM
MnCl2 and 4 mM DTT. This mixture was pre-incubated for
15 min at 30 C and 1 mM substrate (1 mM 4-methylumbelliferyl
phosphate) was added to the reaction mixture which was further
incubated for 30 min at 30 C. 1 lM (+) ABA was added to each
receptor-phosphatase combination to test the functionality of each
receptor. Phosphatase activity was determined by spectroﬂuoro-
metric analysis with the excitation wavelength was 355 nm and
the emission wavelength at 460 nm.
3.2. The structure models and molecular dynamics simulations
3D structures of the complexes PYR1–ABA–HAB1 and pyrabac-
tin (PYV) bound PYR1 dimer were taken from the Protein Data
Bank, PDB ID 3QN1, and 3NJO chains A and B, [20,15–16] and pre-
pared for simulations, see comments in Table 2 and Ref. [10]. In the
crystallographic dimer structure (PDB ID 3NJO) reverse S88P muta-
tion and ligands PYV/P2M removal/replacement with two ABA
have been done. Mutant PYR1 constructs were produced in silico
by mutating the ligand-removed wild type structures (with proline
residue at position 88) with Accelrys Discovery Studio software
[21]. All constructed regions were optimized. Some of the mutated
constructs were additionally in vacuominimized without restraints
in order to eliminate steric clashes. Minimizations, equilibrations
and production MD simulations were carried out using Gromacs
v4.0.7 package [22] with OPLS force ﬁelds. Starting models of WT
PYR1 complexes and mutant systems were minimized in vacuo
for 10000 steps of steepest descent minimization, after which the
systems were solvated and counterions added. Next, steepest des-
cent minimization was carried out as described elsewhere [10], fol-
lowed by system heating employing the Berendsen thermostat.
NVT equilibration was made subsequently. The last equilibration
step and the production simulations were conducted at 310 K tem-
perature and 1 atm pressure with isotropic pressure coupling (NPT
ensemble) and bond length restrained with the LINCS algorithmsimulations and analysis.
PYR1–HAB1 complex
ABA extracted from 3QN1.pdb with parts of HAB1 reconstructed
[15]
O [16]
NJO
3QN1.pdb [15], with parts of HAB1 reconstructed
d, and S88P Mutant models based on 3QN1.pdb, ABA extracted with parts of
HAB1 reconstructed [15]
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cols can be found in Ref. [10]. Overall, the mutant PYR1 dimer sys-
tems consisted of approximately 6000 atoms (or 350 residues),
whereas the mutant PYR1–HAB1 systems comprised approxi-
mately 8000 atoms (500 residues). The explicit water solvent con-
tained 100000–125000 atoms. The production simulations were
performed with 1 fs time steps from 20 ns to 50 ns depending on
the system, and snapshots saved every 20 fs in order to analyze
the essential collective dynamics.
3.3. Essential collective dynamics (ECD) of PYR1 complexes
The mutagenized PYR1 constructs were analyzed as homodi-
mers or in the PYR1–PP2C complex employing ECD methodology,
as described earlier [10]. ECD is a novel method that allows prob-
ing of persistent structural properties of proteins based on short (a
few hundreds of picoseconds) all-atom molecular dynamic trajec-
tories [11–14]. The ECD method relies upon a recently developed
statistical-mechanical framework [11,13], according to which a
macromolecule can be described by a set of generalized Langevin
equations with essential collective coordinates, which can be
deduced by applying principal component analysis (PCA) on MD
trajectories. In this framework, the protein can be represented by
an all-atom image f~r1;~r2; . . . ;~rNg in the 3K dimensional space of
essential collective coordinates, where N is the number of atoms
in the protein, and K is the number of essential components (PCA
eigenvectors) which sample approximately 90% or more of the
total displacement in a MD trajectory of the protein. In the pro-
tein’s image, the distances between atoms dij ¼ j~ri ~rjj represent
the degree of dynamic correlation: short distances dij indicate that
atoms i and j move coherently regardless of their proximity in 3D
structure, whereas larger distances represent a relatively indepen-
dent motion. A suite of simple structural descriptors, such as main
chain ﬂexibility proﬁles, domains of correlated motion, and inter-
molecular and intra-molecular correlation maps have been derived
within the ECD framework, validated against X-ray [10] and NMR
[11–14,23] structural data, and successfully employed to analyze
dynamics of proteins and protein–ligand complexes
[10,12,14,23–25]. The ECD method does not require exhaustive
sampling of the conformational space in order to draw accurate
predictions. Short sub-nanosecond segments of MD trajectories
are usually sufﬁcient for a compatibility of the predictions with
NMR experiments representing signiﬁcantly longer time regimes
[11–14,23].
The dynamics of PYR1 constructs were characterized primarily
employing ECD derived correlation maps and ﬂexibility proﬁles.
The ECD correlation maps represent distances dij between images
of atoms in the space of essential collective coordinates, and the
main chain ﬂexibility proﬁles FCai ¼ j~rCai ~eCai j are deﬁned as dis-
tances between images of Ca atoms, ~rCai , and the centroid over
the images of all Ca atoms,~eCai ¼ 1NCa
P
~rCai . A more detailed discus-
sion of the ECD descriptors can be found elsewhere [12,14].
Here, ECD main chain ﬂexibility proﬁles and correlation maps
were obtained with K = 20. For each construct considered, we
employed 100 segments, each of 20 fs, from the last 20 ns of the
MD trajectories, to obtain the averaged data for the analysis. The
ECD method allows analyzing the dynamics of both main-chain
[10–12,14,23,25] and side-chains [14,24,25] of a protein; however
in this work we have concentrated on main-chain Ca atoms since
their motion represents the most robust trends of the collective
dynamics.
In our comparative analysis of PYR1 mutants, we have exten-
sively employed the difference correlation maps relative to a con-
trol system. We deﬁne the difference correlation descriptor by
DdACij ¼ ðdAij  dCijÞ; ð1Þwhere dAij and d
C
ij represent the degree of dynamic correlation
between Ca atoms i and j in the analyzed construct and in the con-
trol construct, respectively. With this deﬁnition, positive values of
difference descriptor DdACij indicate that correlation is stronger in
the analyzed system than in the control, and negative values sug-
gest that correlation of is weaker than in the control. By doing such
analysis, subtle differences of the molecular dynamics can be
revealed, which are difﬁcult to capture by other methods.Author contributions
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